Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density.
Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density.
复制标题
DOI:
10.1038/s41598-021-92508-1
复制
发表时间:
2021-06-22
影响因子:
4.6
通讯作者:
Masala G
中科院分区:
文献类型:
--
作者:
Bendinelli B;Vignoli A;Palli D;Assedi M;Ambrogetti D;Luchinat C;Caini S;Saieva C;Turano P;Masala G
Mammographic breast density (MBD) is a strong independent risk factor for breast cancer (BC). We designed a matched case–case study in the EPIC Florence cohort, to evaluate possible associations between the pre-diagnostic metabolomic profile and the risk of BC in high- versus low-MBD women who developed BC during the follow-up. A case–case design with 100 low-MBD (MBD ≤ 25%) and 100 high-MDB BC cases (MBD > 50%) was performed. Matching variables included age, year and type of mammographic examination. 1H NMR metabolomic spectra were available for 87 complete case–case sets. The conditional logistic analyses showed an inverse association between serum levels of alanine, leucine, tyrosine, valine, lactic acid, pyruvic acid, triglycerides lipid main fraction and 11 VLDL lipid subfractions and high-MBD cases. Acetic acid was directly associated with high-MBD cases. In models adjusted for confounding variables, tyrosine remained inversely associated with high-MBD cases while 3 VLDL subfractions of free cholesterol emerged as directly associated with high-MBD cases. A pathway analysis showed that the “phenylalanine, tyrosine and tryptophan pathway” emerged and persisted after applying the FDR procedure. The supervised OPLS-DA analysis revealed a slight but significant separation between high- and low-MBD cases. This case–case study suggested a possible role for pre-diagnostic levels of tyrosine in modulating the risk of BC in high- versus low-MBD women. Moreover, some differences emerged in the pre-diagnostic concentration of other metabolites as well in the metabolomic fingerprints among the two groups of patients.
登录
查看更多内容
影响因子:
2.6
作者:
Conroy, Shannon M.;Pagano, Ian;Maskarinec, Gertraud
通讯作者:
Maskarinec, Gertraud
影响因子:
6.1
作者:
Bi X;Henry CJ
通讯作者:
Henry CJ
影响因子:
7.7
作者:
Lecuyer, Lucie;Bala, Agnes Victor;Touvier, Mathilde
通讯作者:
Touvier, Mathilde
影响因子:
11.5
作者:
Hart, Christopher D.;Vignoli, Alessia;Di Leo, Angelo
通讯作者:
Di Leo, Angelo
影响因子:
2.9
作者:
Bai, Jie;Zhang, Xiaoyu;Wang, Zunyi
通讯作者:
Wang, Zunyi